All In Biotech

Drug Trial Radar · NCT02281201

Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects

An Open-label, Uncontrolled, Single-arm, Multicenter Phase IIIb Study to Assess the Efficacy and Safety of BE1116 in Japanese Subjects Receiving Vitamin K Antagonist Therapy With an Elevated INR and Either Acute Major Bleeding or a Requirement for Urgent Reversal of Vitamin K Antagonist Therapy for a Surgical or Invasive Medical Procedure

Last checked: Nov 19, 2026Latest source record: May 4, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

11

Actual

Start

Oct 2014

Primary completion

Jan 2016

Study completion Mar 2016

Sponsor

Lead sponsor
CSL BehringIndustry
Sponsor type
Industry
First posted
Nov 3, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate efficacy and safety of a Prothrombin Complex Concentrate (PCC), BE1116. BE1116 will be used for the rapid reversal of coagulopathy induced by vitamin K antagonists in Japanese subjects who require immediate correction of international normalized ratio (INR) due to a major bleed or emergency surgery.

Conditions

  • Acute Major Bleeding
  • Reversal of Coagulopathy

Interventions

  • BE1116 (Prothrombin Complex Concentrate)Biological

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Subjects With a Rapid Reversal of VKA EffectTime frame: At baseline and at 30 minutes after the end of infusion

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Nippon Medical School Hospital

    Sendagi, Bunkyo, Japan

  • Kyushu Medical Center

    Chūōku, Fukuoka, Japan

  • Nippon Medical School Chiba Hokusoh Hospital

    Kamagari, Inzai, Japan

  • Kurashiki Central Hospital

    Miwa, Kurashiki, Japan

  • Osaka National Hospital

    Chuo-ku, Osaka, Japan

  • Kinki University

    Higashiosaka, Osaka, Japan

  • National Cerebral and Cardiovascular Center

    Suita, Osaka, Japan

  • Tohoku University Hospital

    Aoba-ku, Sendai, Japan

  • National Center for Global Health and Medicine

    Toyama, Shinjuku, Japan

  • Osaka University Hospital

    Yamadaoka, Suita, Japan

  • St. Luke's International Hospital

    Chūō, Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.